Trailing-twelve-month (TTM) revenue is $361.06 Billion with a year-over-year growth of +9.62%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $83,331,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q4 FY2025Period ended 2025-12-31 | $80,039,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-31 | $83,161,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-04 |
| Q2 FY2026Period ended 2026-06-30 | $114,529,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-03 |
| TTM revenue | $361,060,000,000 |
Current P/S: $680,768,999,600 market capitalization ÷ $361,060,000,000 TTM revenue = 1.89x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $114.53B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-31 · USD | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Chemical Non Us | $20.2B | $17.7B | $14.6B | $16.6B | $16.9B | N/A |
| Chemical Products | N/A | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $115.9B | $172.5B | $249.4B | $207.3B | $200.6B | $385.5B |
| United States | $62.7B | $104.2B | $149.2B | $127.4B |
$361.06B
$361.06 Billion
+9.62%
vs. $329.37B a year ago (TTM)
+10.96%
5 Year compound annual growth rate
1 Year
+9.62%
3 Year
+1.54%
5 Year
+10.96%
10 Year
+4.76%
15 Year
(1.10%)
20 Year
(0.36%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $323.90B | ($15.34B) | (4.52%) |
| 2024 | $339.25B | +$4.55B | +1.36% |
| 2023 | $334.70B | ($63.98B) | (16.05%) |
| 2022 | $398.68B | +$121.98B | +44.09% |
| 2021 | $276.69B | +$98.12B | +54.95% |
| 2020 |
TTM Growth
+9.62%
3-Year CAGR
+1.54%
5-Year CAGR
+10.96%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:00.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $18.9B |
| Chemical United States | $12.2B | $9.7B | $8.5B | $12.0B | $10.7B | N/A |
|---|
| Downstream Non US | $147.0B | $70.5B | $92.6B | N/A | N/A | N/A |
|---|
| Downstream United States | $74.3B | $134.5B | $48.3B | N/A | N/A | N/A |
|---|
| Energy Products | N/A | N/A | N/A | N/A | N/A | $217.8B |
|---|
| Energy Products Non US | N/A | N/A | N/A | $130.4B | $188.2B | N/A |
|---|
| Energy Products United States | N/A | N/A | N/A | $78.5B | $117.8B | N/A |
|---|
| Income From Equity Affiliates | N/A | N/A | N/A | N/A | N/A | $5.3B |
|---|
| Other Revenue | N/A | N/A | N/A | N/A | N/A | $2.1B |
|---|
| Specialty Products | N/A | N/A | N/A | N/A | N/A | $17.3B |
|---|
| Specialty Products Non US | N/A | N/A | N/A | $12.5B | $13.7B | N/A |
|---|
| Specialty Products United States | N/A | N/A | N/A | $4.9B | $6.2B | N/A |
|---|
| Upstream | N/A | N/A | N/A | N/A | N/A | $55.7B |
|---|
| Upstream Non Us | $15.2B | $13.8B | $8.7B | $12.9B | $30.6B | N/A |
|---|
| Upstream United States | $10.4B | $9.4B | $5.9B | $8.9B | $14.6B | N/A |
|---|
| $138.7B |
| $276.9B |
| $178.57B |
| ($77.01B) |
| (30.13%) |
| 2019 | $255.58B | ($23.75B) | (8.50%) |
| 2018 | $279.33B | +$42.17B | +17.78% |
| 2017 | $237.16B | +$36.53B | +18.21% |
| 2016 | $200.63B | ($39.23B) | (16.35%) |
